Insurance Coverage Guide · Last verified: June 2026
Does Kaiser Cover Veozah? Coverage by Plan, Cost, and What to Do If You’re Denied (2026)
Does Kaiser cover Veozah? It depends on your Kaiser region and your exact plan. Several Kaiser plans list Veozah (fezolinetant, a non-hormonal hot-flash pill), usually with prior authorization and sometimes step therapy or a higher drug tier. Some, like Kaiser Northwest, treat it as non-formulary but still cover members who meet set criteria for 12 months. Confirm your plan’s rules and cost in your member account.
If your refill was fine last month and got rejected today, take a breath. A denial at the pharmacy is not always the final word — and what happens next depends entirely on whyit was denied. Below, we map every path Kaiser’s own documents reveal.
Your first 30-second read
| What your plan says | What it probably means | Your next move |
|---|---|---|
| A tier number plus PA/QL | It’s listed, but needs approval and may cap how much you get at once | Open your plan’s prior-authorization criteria |
| Non-formulary | Not on the standard list, but an exception may still be possible | Ask for the exception criteria |
| “Not covered” at the counter | Could be a missing prior auth, the wrong pharmacy, a benefit exclusion, or missing records | Get the written rejection reason in your hands |
| No public result for your plan | Coverage is simply unknown from the outside | Check your member portal and call the number on your ID card |
PA = prior authorization (your plan must approve the drug before it pays). QL = quantity limit (a cap on how much you can get at once). We define the rest as we go.
This wall is real, and you’re not the first to hit it. At least one Kaiser member publicly described it: her Veozah was suddenly no longer covered, and she was quoted $1,814.06 for a three-month supply while she pursued a grievance. That account is one person’s experience — not proof of a universal Kaiser policy, price, or appeal outcome. But it captures the moment a lot of women land on this page: a medicine that was helping, gone overnight, with a scary number attached.
We’re The HRT Index — the independent menopause HRT decision layer for women — and we did the tedious part for you. We pulled Kaiser’s own plan documents and prior-authorization forms, the FDA’s current label, and the manufacturer’s assistance terms, then turned them into one plain-English map.
This page is for you if…
- ✓Kaiser rejected a new prescription or a refill for Veozah.
- ✓Your doctor said “Kaiser may not cover it” or “you’ll need prior authorization.”
- ✓You want to know what paperwork might be missing — before you pay anything.
- ✓You’re trying to estimate the coverage path before you fill the prescription.
This page can’t tell you…
- ×Whether Veozah is medically right for you (only your clinician can).
- ×Your exact copay without your specific benefit document.
- ×Whether an appeal will be approved.
- ×Whether a rule from a different Kaiser region applies to your plan.
Your situation changes the answer
Find My HRT Path
The right online HRT provider isn't the same for every woman. It depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state — and some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider, and to flag when online care isn't the right starting point, before your first consult.
- What it asks: your symptoms, age and uterus status, medication route preference, insurance or cash-pay situation, and state
- What you get: a personalized shortlist of online HRT providers matched to your situation, with verified pricing, plus a clear flag when online care isn't the right starting point
- Cost: free · about 60 seconds · no signup
Does Kaiser cover Veozah in every region?
No.Kaiser doesn’t run one nationwide drug list for every member. Kaiser’s own guidance says plans can exclude drugs, limit quantities, and apply different copays depending on your coverage. So a “yes” you read for one region or employer plan is never proof your plan covers Veozah — your exact plan decides it.
Here’s the thing to understand. Four different things can all be true at once:
- •Veozah appears on a formulary (the plan’s list of covered drugs).
- •A prior authorization is still required before the claim actually pays.
- •You have to meet clinical rules to qualify.
- •Even an approved claim can leave you with real cost sharing.
A formulary PDF you find online usually can’t tell you whether you’ve met your deductible, what your specific employer plan negotiated, which pharmacy you must use, your final coinsurance, or whether the paperwork your doctor sent will satisfy the rules. That gap — between “listed somewhere” and “covered for me” — is where people get stuck.
There is no universal yes-or-no answer to “does Kaiser cover Veozah.” Anyone who gives you a flat “yes” is guessing. A listing is not a guaranteed approval, and a tier is not a price. Instead of a national promise, we separated every public finding by the exact plan document, told you what each one does and doesn’t prove, and gave you a path to confirm your own answer.
Want your answer instead of a general one? Tell us your Kaiser region and plan type, and The HRT Index’s Find My HRT Path toolpoints you to the path most likely to fit your situation — and flags when to bring in your Kaiser OB/GYN first.
Start Find My HRT Path \u2192On your phone, this button stays with you as you scroll.
Which Kaiser plans list Veozah in 2026?
Public 2026 records show several different coverage paths, not one rule. Washington plans we reviewed list Veozah at Tier 3 with prior authorization and a quantity limit. Georgia varies by plan (Tier 3 to Tier 5, all with prior authorization). Kaiser Northwest treats it as non-formulary but covers qualifying members for 12 months. Several California commercial formularies don’t list it at all, but publish a non-formulary exception pathway.
Below is our Kaiser Veozah Coverage Map — a June 2026 audit of selectedpublic Kaiser plan documents. It is not every Kaiser plan, and it is not your guaranteed benefit. Read each row as “here’s what this document shows, now confirm yours.” A blank space means that document didn’t state something — not that no restriction exists.
Kaiser Veozah Coverage Map (selected public documents, June 2026)
| Kaiser plan / document | What the public record shows | Restriction noted | Source & effective date | What you still need to confirm |
|---|---|---|---|---|
| Northwest (commercial) | Non-formulary, but covered for members who meet the criteria | Step therapy (two non-hormonal trials); OB/GYN or hematology/oncology prescriber; recent liver labs. No quantity limit. | Kaiser NW Veozah criteria, effective May 7, 2026 | Your copay; whether you meet the trial and lab criteria |
| Washington — Core & Access PPO; a Medicare large-employer 3-tier plan | Listed at Tier 3 | Prior authorization + quantity limit (the public rows don’t state the number) | Named WA plan formularies, effective June 1, 2026 | Your copay; the exact quantity limit; the clinical criteria |
| Hawaii — KPIC Added Choice | Listed at Tier 3 with a “$$” marker (estimated cost share over $100 up to $250) | No PA/QL shown on that row | Named HI plan formulary, effective April 1, 2026 | Your actual cost; whether any other restriction applies |
| Georgia — varies by plan | Tier 5 (specialty) on the five-tier benefit formulary; Tier 4 on the Mid/Large Group four-tier; Tier 3 on the State Employee Health Benefit; Tier 4 on the FEHB formulary | Prior authorization on each | Named GA plan formularies (2026) | Which formulary is yours; your copay; the criteria |
| Colorado — KPIC PPO / Choice | Listed; the plan flags some drugs as maintenance medications (MO) that must be filled at a Kaiser or Kaiser mail-order pharmacy after the first fill (Choice PPO) | Confirm tier; possible MO fill rule | KPIC Colorado formulary, effective April 1, 2026 | Your tier; whether MO applies to you |
| Mid-Atlantic (DC/MD/VA) — Commercial, Exchange, FEHB; and Maryland Medicaid | A dedicated Veozah prior-authorization pathway | Specialist prescriber, symptom severity, safety screening, why hormones aren’t used, prior non-hormonal options; initial 30-day supply | Kaiser Mid-Atlantic Veozah PA forms (confirm current version) | 3 months initial; 12 months continuation (needs a documented 50% drop in symptoms) |
| California — varies by plan | Northern and Southern California Commercial HMO and California Marketplace formularies reviewed did not list Veozah, but publish a non-formulary exception pathway. A Bernard J. Tyson School of Medicine student EPO formulary lists it at Tier 3 (non-formulary/non-preferred brand). | Non-formulary exception likely required | Named CA plan formularies (2026) | Your plan’s exact status and exception route |
A few honest notes on this map. The Northwest criteria are the most detailed public Kaiser criteria we verified, which is why we lean on them below — but they’re written for one region and shouldn’t be stretched to your plan. The Mid-Atlantic continuation rule is strict: to keep coverage past the first few months, the form looks for a documented 50% reduction in how often or how badly your hot flashes hit. And where a plan’s document didn’t state a number, we say “confirm” rather than guess.
The right online HRT provider isn’t the same for every woman — it depends on your symptoms, medication preference, risk history, insurance situation, and state. Use The HRT Index’s Find My HRT Path toolto match your situation to the right provider, and to flag when online care isn’t the right starting point.
Match me to the right provider \u2192What does Kaiser require before it approves Veozah?
The Kaiser documents we reviewed commonly ask for three things: proof your hot flashes are moderate to severe, proof you’ve already tried (or can’t take) cheaper non-hormonal options, and recent liver lab results. The exact requirements and approval periods differ by plan — some approve 12 months at a time, others start with three. Meeting the criteria is what turns a “no” into a “yes.”
Proof your symptoms are significant
Kaiser’s documents look for hot flashes and night sweats (doctors call these vasomotor symptoms, or VMS) bad enough to interfere with your sleep or daily life — not the occasional warm moment. Your clinician documents how often they happen, how severe they are, and how they affect you. To be clear, this is about accurate documentation — describe what’s actually happening, not more.
Proof you tried cheaper options first (step therapy)
“Step therapy” means the plan asks you to try lower-cost treatments before it pays for a pricier one. This is the big one for Veozah.
Kaiser Northwest’s current criteria (effective May 7, 2026) say a new start generally requires that you’ve failed an adequate trial — about four weeks — of two of these non-hormonal options, unless you have a contraindication, allergy, or intolerance:
- •SSRIs (a type of antidepressant also used for hot flashes): citalopram, escitalopram, paroxetine
- •SNRIs (a related class): venlafaxine, desvenlafaxine
- •Gabapentinoids (nerve-calming medicines that can ease night-time symptoms): gabapentin, pregabalin
- •Oxybutynin (a bladder medicine that can reduce sweating) — this one can count toward your two, but you’re not required to try it
You don’t always have to completea trial. A documented allergy, contraindication, or real intolerance can count instead — your doctor just explains why each option was stopped or wasn’t appropriate. The rules are lighter if you’re already on Veozah (more below). The Mid-Atlantic forms ask similar prior-treatment questions, though the exact list varies, so don’t assume every Kaiser region uses the identical drugs.
Who has to write the prescription
This surprises people. In Kaiser Northwest’s criteria, Veozah must be prescribed by an OB/GYN or a hematology/oncology provider. A Mid-Atlantic form asks whether the prescriber is an OB/GYN or gynecologic-oncology specialist. That’s a planrequirement, not a universal medical rule — so if your prescription came from primary care, ask whether your plan requires the named specialist to prescribe or document the request.
New start vs. already taking Veozah
The pathway depends on the plan. In Northwest, members already taking Veozah generally need just one prior non-hormonal trial instead of two. But the Mid-Atlantic forms treat new Kaiser members who started Veozah outside Kaiser as new starts who must meet all the initial criteria. Don’t assume your prior history automatically carries over.
| If you’re starting Veozah | If you’re already taking it (or renewing) |
|---|---|
| Full treatment-history documentation; in Northwest, two prior trials | In Northwest, one prior trial; plus proof it’s working |
| Baseline liver test before you begin | Liver monitoring records on the required schedule |
| Initial authorization (12 months in NW; 3 months in some Mid-Atlantic plans) | Renewal criteria — including documented symptom improvement |
How long approval lasts
Real, verified examples from Kaiser’s own documents:
- •Northwest: 12 months for a qualifying new start. Continued use is approved for another 12 months when symptoms have partially or fully resolved. Starting at age 65, if symptoms have fully resolved, the criteria call for a trial off the medicine to see whether it’s still needed, repeated every two years.
- •Mid-Atlantic (Commercial, Exchange, FEHB) and Maryland Medicaid: 3 months initially, then 12 months for continuation if it’s working.
One thing worth saying plainly: FDA approval does not force any plan to cover a drug automatically. If your plan’s preferred option is a reasonable fit, Kaiser can ask you to try it first. When it’s nota fit, your doctor documents why — and that documentation unlocks the exception.
See the prep steps for my situation \u2192
How do I check whether my exact Kaiser plan covers Veozah?
Start with your exact plan, not just “Kaiser.” Find your region, full plan name, and plan year in your member account, search both “Veozah” and “fezolinetant,” and write down every tier and restriction code you see. Then confirm your real cost and the clinical rules by calling the number on your ID card.
Your seven-step check
- 1Find your full plan name and plan year (it’s in your member account — “Kaiser Northwest” or “Tier 3” alone isn’t enough).
- 2Confirm who runs your drug benefit — Kaiser directly, or another pharmacy benefit manager.
- 3Search both names: Veozah and its generic name, fezolinetant.
- 4Record every code: tier number, PA (prior authorization), QL (quantity limit), ST (step therapy), NF (non-formulary), or SP (specialty).
- 5Open the linked criteria — the prior-authorization or coverage document, if there is one.
- 6Ask for the dollar amount after your deductible and after approval — not just the tier.
- 7If the answer still isn’t clear, call member services (the number on your ID card) and ask: “Does my plan require prior authorization for fezolinetant / Veozah, and if so, what criteria does my doctor need to meet?”
What does Veozah actually cost with Kaiser?
Your real cost depends on your plan tier, deductible status, and whether you have commercial, Medicare, or Medicaid coverage. For reference, Veozah’s wholesale acquisition cost is $583.50 per 30-day supply (as of January 14, 2026). Without insurance, cash prices at major pharmacies typically range from about $580 to $620 per month, though GoodRx and SingleCare discount cards can sometimes reduce that (check whether Kaiser’s network pharmacy accepts them first).
| Coverage type | Savings card works? | Notes |
|---|---|---|
| Commercial (employer / marketplace) Kaiser plan | Possibly — if your pharmacy can process it | Confirm with both Kaiser pharmacy and the savings program before filling. |
| Kaiser Medicare (Part D) | No | Manufacturer excludes government-program claims. Ask about Medicare Extra Help or other assistance. |
| Kaiser Medi-Cal / Medicaid | No | Same exclusion. Maryland Medicaid has a separate PA pathway; confirm your state’s rules. |
| Uninsured | Patient Assistance Program may apply | Eligible patients may pay $0 through Astellas’s PAP — treat as an application-based program, not guaranteed. |
Sources: Astellas Veozah Savings Program; Medicare Extra Help; Veozah Support Solutions (patient assistance)
You’ll find forum posts about trying an outside pharmacy when a Kaiser pharmacy won’t take a card. We won’t hand you a “workaround” as instructions, because network and benefit rules vary and the wrong move can cost you. Instead, confirm the allowed pharmacies with both Kaiser and the savings program.
What if Kaiser still won’t cover Veozah?
A final “no” doesn’t make another medicine automatically right for you — but you have real options. The sensible next paths are a clinician-guided alternative your plan does cover, a second opinion, manufacturer assistance if you qualify, or a different care route matched to your situation. The goal is relief, and Veozah is one road to it, not the only one.
Which alternatives are named in Kaiser’s criteria?
Kaiser Northwest’s Veozah criteria name a specific set of lower-cost, non-hormonal options you may need to try first. These are the ones explicitly named — and most are inexpensive generics Kaiser generally covers:
| Option named in the criteria | Type | Veozah-style scheduled liver testing? | Note |
|---|---|---|---|
| Citalopram, escitalopram, paroxetine | SSRI | No | Paroxetine: avoid at 64+ or with tamoxifen, per the criteria |
| Venlafaxine, desvenlafaxine | SNRI | No | Can help hot flashes and mood |
| Gabapentin | Gabapentinoid | No | Often used for night-time symptoms |
| Pregabalin | Gabapentinoid | No | A federally Schedule V controlled substance |
| Oxybutynin | Bladder medicine | No | Can count toward your trials, but isn’t required |
“No” in that middle column means these don’t carry Veozah’s specific liver-testing schedule — not that they have no precautions. Every medicine has its own considerations; your clinician weighs them.
Other FDA-approved options to ask about
Beyond the step-therapy list, two other FDA-approved, non-hormonal choices are worth raising with your doctor:
- •Brisdelle (paroxetine 7.5 mg) is the only SSRI the FDA has approved specifically for hot flashes. Its label notes that paroxetine can reduce how well tamoxifen works, so if you take tamoxifen, your doctor will weigh that and may suggest avoiding the combination.
- •Lynkuet (elinzanetant), approved by the FDA in October 2025 for moderate-to-severe hot flashes, is a newer non-hormonal option. It has its own monitoring and label requirements — ask your clinician.
Hormone therapy(estrogen, with progesterone if you have a uterus) remains the most effective treatment for hot flashes, according to menopause guidance, and Kaiser plans cover many FDA-approved options. Whether it fits depends on the product, route, your age and timing, and your medical history, so it’s a clinician conversation. Our Kaiser HRT coverage guide covers what Kaiser typically covers on the hormonal side.
Is it the medicine, or the pathway?
Sometimes the real question isn’t “how do I force this one drug through Kaiser.” Kaiser may readily cover a different treatment that works well for you, you might be better served by an in-person specialist, you might want a second opinion, or you may not be sure yet whether you need a non-hormonal pill, systemic hormone therapy, or a local (vaginal) option. That’s a decision worth getting right.
If you’ve weighed it and decided you’d rather go outside Kaiser, here’s the honest picture: an outside prescription does notcancel your Kaiser drug benefit, but Kaiser may still require its own formulary exception or prior authorization, an authorized prescriber, and an eligible network pharmacy before the benefit pays — so confirm visit coverage and prescription coverage separately. Some menopause telehealth services can evaluate you and prescribe; Midi Health, for example, states that its clinicians may include non-hormonal options such as fezolinetant in an individualized care plan, and it accepts a range of insurance — confirm your visit and prescription coverage with them directly. (The HRT Index may earn a commission if you start care through that link, at no extra cost to you; it doesn’t change our findings.)
How to appeal a Kaiser Veozah denial
The denial reason is your roadmap. Here are the most common paths:
| Denial reason | What to add | Route |
|---|---|---|
| Missing clinical information | Diagnosis, symptom severity, past treatments, recent liver labs | Resubmit through your plan’s PA route |
| Step therapy required | Record of what you tried, the result, or a medical reason each option won’t work | Resubmit with full treatment history |
| Non-formulary | Medical-necessity letter from your clinician | Formulary exception request |
| Wrong prescriber specialty | Prescription or co-signature from the required specialist (OB/GYN or oncology) | Work with your prescriber to route correctly |
| Quantity limit exceeded | Corrected quantity if clinically fine; clinical justification if more is needed | Resubmit to match the limit or appeal with justification |
| Safety concern (liver) | Your prescriber’s monitoring plan and current lab results | Discuss with prescriber; don’t skip the safety review |
- ✓Get the written denial reason first. You can’t fix what you can’t see. Call Kaiser member services and ask for the denial in writing if you didn’t receive it.
- ✓For California plans regulated by the DMHC: an eligible medical-necessity denial may qualify for a complaint or Independent Medical Review after the plan’s own grievance process is exhausted.
- ✓For Kaiser Medicare (Part D): you have 65 calendar days from the denial notice to file a redetermination. A standard decision is due within 7 calendar days; an expedited one within 72 hours.
- ✓For Maryland Medicaid: the Kaiser Mid-Atlantic pathway includes an initial three-month approval and a continuation track, but confirmation criteria are strict (50% symptom improvement documented).
CMS Part D coverage determinations → · CA DMHC Independent Medical Review →
What safety checks can delay or block coverage?
Veozah carries an FDA Boxed Warning for serious liver injury, so liver testing is a medical-safety requirement — not just an insurance hurdle. The label calls for liver blood tests before you start, then monthly for the first three months, and again at months six and nine. This is part of why Kaiser’s criteria ask for recent liver results.
Veozah is not HRT
Worth saying clearly: Veozah is an FDA-approved, non-hormonal medication.It is not estrogen, not progesterone, not compounded hormone therapy, and not “natural HRT.” It works on a brain pathway (it’s a neurokinin 3, or NK3, receptor antagonist) that helps control body temperature. The safety profile and the rules are different from hormones.
The liver-test schedule
The current label (updated February 2026) directs liver blood tests — ALT, AST, alkaline phosphatase, and total and direct bilirubin — at these points:
- 1Before you start
- 2Month 1
- 3Month 2
- 4Month 3
- 5Month 6
- 6Month 9
When treatment shouldn’t start
The label says do not start Veozah if your ALT or AST (liver enzymes) is at least 2 times the upper limit of normal, or your total bilirubin is at least 2 times the upper limit of normal. Veozah is also not for people with known cirrhosis, severe kidney impairment or end-stage kidney disease, or anyone taking certain medicines called CYP1A2 inhibitors (a class of drugs that can raise Veozah levels in the body). Your prescriber checks all of this. Some Kaiser criteria also use liver results when deciding coverage, but the insurance consequence depends on your exact plan.
Stop taking Veozah and seek medical attention right away — including liver blood tests — if you notice:
new tiredness, decreased appetite, nausea, vomiting, itching, yellowing of the eyes or skin (jaundice), pale stools, dark urine, or stomach (abdominal) pain. Your clinician may also stop the medicine if your liver tests rise above certain levels.
Source: FDA-approved Veozah prescribing information, current as of February 2026
How we verified this guide
We built this page from Kaiser’s own plan documents, the current FDA label, and the manufacturer’s published terms — then dated every finding and scoped it to its exact document. Where we couldn’t confirm a plan’s rules, we said so instead of guessing.
What we actually verified
- ✓Kaiser’s own explanation that plan formularies and restrictions vary
- ✓Kaiser Northwest’s detailed Veozah coverage criteria (effective May 7, 2026)
- ✓That dedicated Veozah prior-authorization pathways exist in Kaiser Mid-Atlantic and Maryland Medicaid
- ✓Veozah’s FDA approval (May 2023), Boxed Warning (December 2024), and the liver-test schedule and contraindications in the current label (updated February 2026)
- ✓The Veozah Savings Card and Patient Assistance terms (checked June 2026)
- ✓Current cash-price ranges from pharmacy pricing sources (March–June 2026)
What we did not verify
- ×Any individual member’s benefit, deductible status, or final copay
- ×Private member-portal results
- ×Whether any specific appeal will be approved
- ×The exact quantity limits, which several public documents don’t state
- ×Any newer revision of a Kaiser form published after June 2026
The HRT Index Verification Standard:This guide follows our documented process for reviewing coverage and providers: we read every published price and term, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule. It’s a process, not a numeric score. When we evaluate providers more broadly, we weigh exactly five things, in this order: clinical legitimacy, care quality, medication fit, price transparency, and access.
By The HRT Index Editorial Team. Last verified: June 2026. This guide is editorial research. It was not reviewed by a clinician, and it isn’t medical advice. The HRT Index is an independent menopause-HRT decision resource for women. Some links in this guide are partner links, which means we may earn a commission if you start care with a provider like Midi Health, at no extra cost to you. That never changes the facts above or who we’d point you to. See our affiliate disclosure and, before using the matching tool, our consumer health data and privacy policy.
Frequently asked questions about Kaiser and Veozah
- Is Veozah on the Kaiser formulary?
- It depends on your plan. Some Kaiser plans list Veozah (often at a higher tier with prior authorization), while Kaiser Northwest treats it as non-formulary but still covers members who meet its criteria. Several California commercial formularies don’t list it but offer an exception pathway. Check your exact plan’s drug list.
- Does Kaiser require prior authorization for Veozah?
- In the plans we reviewed, yes — Veozah commonly needs prior authorization, and often step therapy too. That means your doctor must request approval and usually show you’ve tried cheaper non-hormonal options first.
- Does Kaiser Northwest cover Veozah?
- Kaiser Northwest treats Veozah as non-formulary but covers qualifying members for 12 months. You generally need an OB/GYN or hematology/oncology prescriber, documented moderate-to-severe symptoms, failed trials of two non-hormonal options, and recent liver labs.
- Does Kaiser Washington cover Veozah?
- The 2026 Washington plan documents we reviewed list Veozah at Tier 3 with prior authorization and a quantity limit. The listing doesn’t reveal your exact copay or the clinical criteria, so confirm both with your plan.
- Does Kaiser Medicare cover Veozah?
- It can. Some Kaiser Washington Medicare large-employer plans list Veozah at Tier 3 with prior authorization and a quantity limit; other Kaiser Medicare coverage depends on the exact Part D formulary. A coverage determination or exception is a review process for a restricted drug — not proof it’s covered. Standard Medicare decisions come within 72 hours, expedited within 24.
- Does Kaiser Medicaid cover Veozah?
- Sometimes — Medicaid coverage depends on the state program. Kaiser’s Maryland Medicaid documents include a Veozah prior-authorization pathway, with an initial approval of about three months and a 12-month continuation if it’s working.
- Will Kaiser make me try another medication first?
- Often, yes. Step therapy is common for Veozah, meaning you may need to try (or document why you can’t take) options like an SSRI, SNRI, gabapentin, or oxybutynin before Kaiser approves it.
- How long does a Kaiser Veozah authorization last?
- It varies by plan. Kaiser Northwest approves qualifying members for 12 months. Some Mid-Atlantic plans approve about three months initially, then 12 months for continuation if it’s working.
- Are the rules different if I’m already taking Veozah?
- Sometimes. Kaiser Northwest’s pathway for members already taking it requires one prior non-hormonal trial instead of two. But a Mid-Atlantic form treats new Kaiser members who started Veozah elsewhere as new starts who must meet all initial criteria. Don’t assume your history carries over.
- Can I appeal if Kaiser denies Veozah?
- Yes. Get the written denial reason, fix any missing paperwork, and file a formulary exception or appeal by the deadline on your notice. For a California plan regulated by the Department of Managed Health Care, an eligible medical-necessity denial may qualify for a DMHC complaint or Independent Medical Review after the plan’s grievance; Medicare and Medi-Cal follow different routes.
- Can I use the Veozah Savings Card with Kaiser?
- Possibly, if you have an eligible commercial Kaiser plan and your pharmacy can process it. It does not work with Kaiser Medicare or Medi-Cal/Medicaid plans.
- Does Veozah require liver tests?
- Yes. The label requires liver blood tests before starting and at months 1, 2, 3, 6, and 9 because of a Boxed Warning for serious liver injury. Stop the medicine and seek medical attention if you notice symptoms like jaundice, dark urine, or new fatigue.
- Is Veozah hormone replacement therapy?
- No. Veozah is an FDA-approved, non-hormonal medication. It is not estrogen, progesterone, or compounded hormone therapy, and it shouldn’t be grouped with them.
- How do I find the formulary for my exact Kaiser plan?
- Log into your member account, find your full plan name and year, and search both “Veozah” and “fezolinetant.” Note any tier or restriction codes, then confirm your cost and criteria with the number on your ID card.
- Does a Kaiser drug-information page mean Veozah is covered?
- No. A drug encyclopedia page explains what a medicine is and how it’s used — it is not a coverage decision. Only your plan’s formulary and benefit determine whether Veozah is covered for you.
The bottom line
Kaiser doesn’t run one national Veozah rule — your region and plan decide it. Several Kaiser plans cover Veozah with prior authorization and step therapy; Kaiser Northwest covers qualifying members for 12 months; some California plans require a non-formulary exception. Your first move is to find your exact plan name, search both “Veozah” and “fezolinetant,” and write down every restriction code. A denial is not always the final word — the reason on the letter is your roadmap, and most denials have a clear next step.
Still not sure which HRT program is right for you? Take our free 60-second matching quiz.
Take the free 60-second matching quiz \u2192Sources
- 1. Kaiser Permanente — How the drug formulary works (plans and restrictions vary)
- 2. Kaiser Permanente, Northwest — fezolinetant (Veozah) Criteria for Drug Coverage; revised March 12, 2026; effective May 7, 2026 (primary source)
- 3. Kaiser Permanente, Mid-Atlantic States — Veozah (fezolinetant) prior-authorization forms (HMO/Exchange/FEHB and Medicaid/FAMIS) (primary source; confirm current version)
- 4. Kaiser Permanente — 2026 regional formularies: Washington (Core & Access PPO; Medicare large-employer three-tier, eff. June 1, 2026), Hawaii (KPIC Added Choice, eff. April 1, 2026), Georgia (five-tier, Mid/Large Group four-tier, State Employee Health Benefit, FEHB), Colorado (KPIC PPO/Choice, eff. April 1, 2026), and California (Northern/Southern CA Commercial HMO, CA Marketplace, and Bernard J. Tyson School of Medicine EPO)
- 5. FDA / DailyMed — VEOZAH (fezolinetant) prescribing information, current as of February 26, 2026; Boxed Warning added December 2024; FDA approval May 12, 2023 (primary source)
- 6. FDA — Drug safety communication — Veozah Boxed Warning for hepatotoxicity (December 2024)
- 7. FDA — Brisdelle (paroxetine) approval and label (primary source)
- 8. FDA — Lynkuet (elinzanetant) approval, October 2025 (primary source)
- 9. Astellas — Veozah Savings Card and Patient Assistance Program terms (checked June 2026)
- 10. Astellas — Veozah Support Solutions / patient assistance (1-866-239-1637)
- 11. GoodRx and SingleCare — Veozah cash-price snapshots (March–June 2026)
- 12. CMS — Medicare Part D exceptions and coverage determinations (primary source)
- 13. California Department of Managed Health Care — complaints and Independent Medical Review (primary source)
- 14. Medicare.gov — Extra Help 2026
See also
- Aetna Veozah prior authorization: criteria and checklist
- Veozah prior authorization: the complete cross-insurer guide
- Does insurance cover Veozah? 2026 coverage by plan
- Veozah savings card: $0 first month, then $30?
- Veozah cost without insurance 2026
- Veozah vs. HRT: which fits your situation?
- Does Kaiser cover HRT for menopause?
- Non-hormonal menopause options: the full guide
- Find My HRT Path — free 60-second quiz
Your situation changes the answer
Find My HRT Path
The right online HRT provider isn't the same for every woman. It depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state — and some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider, and to flag when online care isn't the right starting point, before your first consult.
Find My HRT Path →